These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35378982)

  • 21. Bioelectrical impedance analysis as an alternative to dual-energy x-ray absorptiometry in the assessment of fat mass and appendicular lean mass in patients with obesity.
    Ballesteros-Pomar MD; González-Arnáiz E; Pintor-de-la Maza B; Barajas-Galindo D; Ariadel-Cobo D; González-Roza L; Cano-Rodríguez I
    Nutrition; 2022 Jan; 93():111442. PubMed ID: 34482097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-operative sarcopenia is predictive of recurrent gastrointestinal bleeding on left ventricular assist device support: A multicenter analysis.
    Klajda M; Trachtenberg B; Araujo R; Estep JD; Masotti M; Teigen L; Schultz J; John R; Martin C; Suarez EE; Cogswell R
    J Heart Lung Transplant; 2022 Jun; 41(6):757-762. PubMed ID: 35105490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Associations of Low Muscle Mass and Function with 10-Year Falls Risk, Incident Fracture and Mortality in Community-Dwelling Older Adults.
    Balogun S; Winzenberg T; Wills K; Scott D; Jones G; Aitken D; Callisaya ML
    J Nutr Health Aging; 2017; 21(7):843-848. PubMed ID: 28717816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia.
    Yamada Y; Nishizawa M; Uchiyama T; Kasahara Y; Shindo M; Miyachi M; Tanaka S
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28753945
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic measures for sarcopenia and bone mineral density.
    Bijlsma AY; Meskers MC; Molendijk M; Westendorp RG; Sipilä S; Stenroth L; Sillanpää E; McPhee JS; Jones DA; Narici M; Gapeyeva H; Pääsuke M; Seppet E; Voit T; Barnouin Y; Hogrel JY; Butler-Browne G; Maier AB
    Osteoporos Int; 2013 Oct; 24(10):2681-91. PubMed ID: 23649802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.
    Drakos SG; Wever-Pinzon O; Selzman CH; Gilbert EM; Alharethi R; Reid BB; Saidi A; Diakos NA; Stoker S; Davis ES; Movsesian M; Li DY; Stehlik J; Kfoury AG;
    J Am Coll Cardiol; 2013 May; 61(19):1985-94. PubMed ID: 23500219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
    George I; Xydas S; Mancini DM; Lamanca J; DiTullio M; Marboe CC; Shane E; Schulman AR; Colley PM; Petrilli CM; Naka Y; Oz MC; Maybaum S
    J Heart Lung Transplant; 2006 Sep; 25(9):1084-90. PubMed ID: 16962470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Perioperative Right Ventricular Support Prevent Postoperative Right Heart Failure in Patients With Biventricular Dysfunction Undergoing Left Ventricular Assist Device Implantation?
    Deschka H; Holthaus AJ; Sindermann JR; Welp H; Schlarb D; Monsefi N; Martens S; Scherer M
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):619-26. PubMed ID: 27321789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies.
    Fonseca GWPD; Garfias Macedo T; Ebner N; Dos Santos MR; de Souza FR; Mady C; Takayama L; Pereira RMR; Doehner W; Anker SD; Negrão CE; Alves MJNN; von Haehling S
    ESC Heart Fail; 2020 Oct; 7(5):3086-3094. PubMed ID: 32860353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?
    Maurer MS; Horn E; Reyentovich A; Dickson VV; Pinney S; Goldwater D; Goldstein NE; Jimenez O; Teruya S; Goldsmith J; Helmke S; Yuzefpolskaya M; Reeves GR
    J Am Geriatr Soc; 2017 Nov; 65(11):2383-2390. PubMed ID: 28940248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordance between muscle mass assessed by bioelectrical impedance analysis and by dual energy X-ray absorptiometry: a cross-sectional study.
    Buckinx F; Reginster JY; Dardenne N; Croisiser JL; Kaux JF; Beaudart C; Slomian J; Bruyère O
    BMC Musculoskelet Disord; 2015 Mar; 16():60. PubMed ID: 25887598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Cachexia in Left Ventricular Assist Device Recipients and the Implications of Weight Gain Early After Implantation.
    Vest AR; Price LL; Chanda A; Sweigart BA; Chery J; Lawrence M; Parsly L; Gulati G; Kiernan MS; Upshaw JN; Kawabori M; Couper GS; Saltzman E
    J Am Heart Assoc; 2023 Jul; 12(13):e029086. PubMed ID: 37382139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of DXA and BIS body composition measurements is highly correlated with physical function-an approach to improve muscle mass assessment.
    Kuchnia AJ; Yamada Y; Teigen L; Krueger D; Binkley N; Schoeller D
    Arch Osteoporos; 2018 Sep; 13(1):97. PubMed ID: 30218261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis.
    Eriksen CS; Kimer N; Suetta C; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G729-G740. PubMed ID: 33729006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation.
    Welp H; Sindermann JR; Deschka H; Martens S; Scherer M
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):627-31. PubMed ID: 26460277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
    Kang G; Ha R; Banerjee D
    J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
    Fülster S; Tacke M; Sandek A; Ebner N; Tschöpe C; Doehner W; Anker SD; von Haehling S
    Eur Heart J; 2013 Feb; 34(7):512-9. PubMed ID: 23178647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.